EP 1296943 A1 20030402 - AMINO ACID DERIVATIVES AND THEIR USE AS MEDICINES
Title (en)
AMINO ACID DERIVATIVES AND THEIR USE AS MEDICINES
Title (de)
AMINSÄURE-DERIVATE UND IHRE VERWENDUNG ALS ARZNEIMITTEL
Title (fr)
DERIVES D'AMINOACIDES ET LEUR APPLICATION A TITRE DE MEDICAMENTS
Publication
Application
Priority
- FR 0101358 W 20010504
- FR 0005758 A 20000505
- FR 0011168 A 20000901
Abstract (en)
[origin: WO0185677A1] The invention concerns novel amino acid derivatives and their use as medicines. Said derivatives have an inhibiting activity towards NO-synthase enzymes producing nitrogen monoxide NO and/or (optionally): either an activity trapping reactive oxygen species (ROS); or an activity regenerating antioxidants such as glutathion or entities trapping reactive oxygen species (ROS) and more generally an influence in the redox status of thiol group.
IPC 1-7
C07C 279/36; C07D 339/04; A61K 31/165; A61K 31/40; A61K 31/155; A61K 31/385
IPC 8 full level
A61K 31/167 (2006.01); A61K 31/198 (2006.01); A61K 31/385 (2006.01); A61K 31/404 (2006.01); A61P 1/04 (2006.01); A61P 1/14 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61P 7/02 (2006.01); A61P 9/00 (2006.01); A61P 9/10 (2006.01); A61P 11/06 (2006.01); A61P 13/12 (2006.01); A61P 15/00 (2006.01); A61P 15/10 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 21/00 (2006.01); A61P 25/00 (2006.01); A61P 25/02 (2006.01); A61P 25/06 (2006.01); A61P 25/08 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/20 (2006.01); A61P 25/22 (2006.01); A61P 25/28 (2006.01); A61P 25/32 (2006.01); A61P 25/36 (2006.01); A61P 27/02 (2006.01); A61P 27/12 (2006.01); A61P 27/16 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 33/10 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01); A61P 39/02 (2006.01); A61P 39/06 (2006.01); A61P 43/00 (2006.01); C07C 279/36 (2006.01); C07D 209/08 (2006.01); C07D 339/04 (2006.01)
CPC (source: EP US)
A61P 1/04 (2017.12 - EP); A61P 1/14 (2017.12 - EP); A61P 3/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 7/02 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 15/10 (2017.12 - EP); A61P 17/00 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/02 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 25/22 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/32 (2017.12 - EP); A61P 25/36 (2017.12 - EP); A61P 27/02 (2017.12 - EP); A61P 27/12 (2017.12 - EP); A61P 27/16 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 31/18 (2017.12 - EP); A61P 33/10 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 39/02 (2017.12 - EP); A61P 39/06 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07C 279/36 (2013.01 - EP US); C07D 339/04 (2013.01 - EP US)
Citation (search report)
See references of WO 0185677A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0185677 A1 20011115; AU 6038601 A 20011120; CA 2407830 A1 20011115; EP 1296943 A1 20030402; JP 2003532703 A 20031105; US 2003166630 A1 20030904; US 6821986 B2 20041123
DOCDB simple family (application)
FR 0101358 W 20010504; AU 6038601 A 20010504; CA 2407830 A 20010504; EP 01934069 A 20010504; JP 2001582278 A 20010504; US 27505702 A 20021031